You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Neuroendocrine

Showing 26 - 50 of 2,013
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Small Cell Lung Cancer, Neuroendocrine Carcinoma Trial in Zhengzhou (ZG006)

Not yet recruiting
  • Small Cell Lung Cancer
  • Neuroendocrine Carcinoma
  • ZG006
  • Zhengzhou, Henan, China
    Henan Cancer Hospital
Aug 6, 2023

Imaging Features in Invasiveness and Prognosis of Pituitary

Recruiting
  • Pituitary Adenoma
  • Neuroendocrine Tumors
  • diagnosed and treated reasonably according to the clinical guidelines and clinical pathways
  • Guangzhou, Guangdong, China
    endocrinology department of the first affiliated hospital of Sun
Aug 24, 2023

Neuroendocrine Tumors Trial in Innsbruck (68Ga-DOTA-MGS5)

Completed
  • Neuroendocrine Tumors
  • Innsbruck, Austria
    Department of Nuclear Medicine, Medical University of Innsbruck
Nov 24, 2023

Neuroendocrine Tumors, Neuroendocrine Carcinoma, Neuroendocrine Cancer Trial in Tampa (Pembrolizumab, Lenvatinib)

Active, not recruiting
  • Neuroendocrine Tumors
  • +2 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Jan 24, 2023

Bronchial and Thymic Neuroendocrine Tumour, Paraganglioma/ Phaeochromocytoma, Medullary Thyroid Carcinoma Trial (Lu-177 DOTATATE

Not yet recruiting
  • Bronchial and Thymic Neuroendocrine Tumour
  • +3 more
  • Lu-177 DOTATATE (Lutathera®)
  • (no location specified)
Nov 1, 2023

Collect Somatuline® Injector Device Preferences of Patients

Not yet recruiting
  • Neuroendocrine Tumors
    • (no location specified)
    Jun 19, 2023

    Neuroendocrine Tumors, Neuroendocrine Tumor of the Lung, Neuroendocrine Tumor of Pancreas Trial in Iowa City, Rochester

    Not yet recruiting
    • Neuroendocrine Tumors
    • +8 more
    • Iowa City, Iowa
    • +1 more
    Nov 23, 2022

    Advanced Gastroenteropancreatic Neuroendocrine Tumor Trial (Lutetium (177Lu) Oxodotreotide Injection;long-acting Octreotide,

    Not yet recruiting
    • Advanced Gastroenteropancreatic Neuroendocrine Tumor
    • Lutetium (177Lu) Oxodotreotide Injection；long-acting Octreotide
    • long-acting Octreotide.
    • (no location specified)
    May 22, 2023

    Neuroendocrine Tumor Trial in Beijing (Al18F-octreotide)

    Recruiting
    • Neuroendocrine Tumor
    • Beijing, Chao Yang, China
      National Cancer Center/Cancer Hospital,Chinese Academy of Medica
    Feb 19, 2023

    Neuroendocrine Carcinoma Trial in Wuhan (Surufatinib and Serplulimab)

    Not yet recruiting
    • Neuroendocrine Carcinoma
    • Surufatinib and Serplulimab
    • Wuhan, Hubei, China
      Cancer Center, Union Hospital, Tongji Medical College, Huazhong
    Feb 18, 2023

    Neuroendocrine Tumors Trial (BI 764532, Carboplatin, Etoposide)

    Not yet recruiting
    • Neuroendocrine Neoplasms
    • BI 764532
    • +3 more
    • (no location specified)
    Nov 10, 2023

    Epiction of Genomic and Genetic Landscape Identifies CCL5

    Completed
    • Colorectal Neuroendocrine Carcinomas (CRNEC); Genomic Landscape; Genetic Landscape; Prognosis; CCL5; PAX5
      • (no location specified)
      Jan 27, 2023

      Frequency for Patients With Gastric Neuroendocrine Carcinoma

      Completed
      • Gastric Neuroendocrine Carcinoma
        • Fuzhou, Fujian, China
          Chang-ming Huang
        Dec 31, 2022

        Adrenal Cortical Carcinoma, Medullary Thyroid Cancer, Thymic Neuroendocrine Carcinoma Trial in Shanghai (individualized mRNA

        Not yet recruiting
        • Adrenal Cortical Carcinoma
        • +3 more
        • individualized mRNA neoantigen vaccine (mRNA-0523-L001)
        • Shanghai, Shanghai, China
          Ruijin hospital, Shanghai Jiao-Tong University School of Medicin
        Nov 19, 2023

        Gastroenteropancreatico Tumors, Neuroendocrine Tumors, Neuroendocrine Tumors Trial run by the National Cancer Institute (NCI)

        Recruiting
        • Gastroenteropancreatico Tumors
        • +2 more
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Jan 19, 2023

        Recurrent Neuroendocrine Tumor, Metastatic Neuroendocrine Tumor Trial in Cleveland (ONC201)

        Completed
        • Recurrent Neuroendocrine Tumor
        • Metastatic Neuroendocrine Tumor
        • Cleveland, Ohio
          Cleveland Clinic Pediatric and Taussig Cancer Institute, Case Co
        Dec 1, 2022

        Neuroendocrine Tumors Trial in Beijing (Al18F-NOTA-LM3, 68Ga-DOTATATE, 68Ga-NODAGA-LM3)

        Recruiting
        • Neuroendocrine Tumors
        • Al18F-NOTA-LM3
        • +2 more
        • Beijing, China
          Peking Union Medical College Hospital
        Sep 20, 2023

        Small Cell Lung Carcinoma (SCLC), Neuroendocrine Tumors Trial (BI 764532, [89Zr]Zr-BI 764532)

        Not yet recruiting
        • Small Cell Lung Carcinoma (SCLC)
        • Neuroendocrine Neoplasms
        • BI 764532
        • [89Zr]Zr-BI 764532
        • (no location specified)
        Jul 31, 2023

        Neuroendocrine Tumor Trial in Beijing (PM8002, FOLFIRI)

        Recruiting
        • Neuroendocrine Neoplasm
        • Beijing, China
          Chinese PLA General Hospital
        May 25, 2023

        Locally Advanced Neuroendocrine Tumor, Metastatic Neuroendocrine Tumor Trial in Houston (Placebo Administration, Questionnaire

        Recruiting
        • Locally Advanced Neuroendocrine Neoplasm
        • Metastatic Neuroendocrine Neoplasm
        • Placebo Administration
        • +2 more
        • Houston, Texas
          M D Anderson Cancer Center
        Jan 31, 2023

        VHL Pancreatic Neuroendocrine Tumors, Von Hippel-Lindau Disease, Neuroendocrine Tumors Trial run by the National Cancer

        Recruiting
        • VHL Pancreatic Neuroendocrine Tumors
        • +2 more
        • 68-Gallium DOTATATE
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Jan 26, 2023

        Menopause Trial in Nanjing (Femoston, Qingxin Zishen Decoction)

        Completed
        • Menopause
        • Nanjing, 南京, China
          Yuxin Zhou
        Nov 9, 2023

        Neuroendocrine Tumors Trial in Beijing (Lutetium[177Lu] Oxodotreotide Injection)

        Not yet recruiting
        • Neuroendocrine Tumors
        • Lutetium[177Lu] Oxodotreotide Injection
        • Beijing, Beijing, China
          Beijing Cancer Hospital
        May 30, 2023

        Small Cell Lung Cancer (SCLC), Large Cell Neuroendocrine Cancer (LCNEC), Neuroendocrine Prostate Cancer (NEPC) Trial (PT217)

        Not yet recruiting
        • Small Cell Lung Cancer (SCLC)
        • +3 more
        • (no location specified)
        Dec 7, 2022

        Neuroendocrine Tumors Trial in Lexington (Telotristat (Low-Dose), Telotristat (High-Dose))

        Recruiting
        • Neuroendocrine Tumors
        • Telotristat (Low-Dose)
        • Telotristat (High-Dose)
        • Lexington, Kentucky
          Markey Cancer Center
        Nov 10, 2022